Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter D Zang

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2025
IDO Believe in ImmunotherapyPeter D Zang, Tanya B Dorff
Annual Review of Medicine|November 21, 2024
CD70: An Emerging Anticancer Target in Renal Cell Carcinoma and BeyondPeter D Zang, Arkhjamil Angeles, Sumanta K Pal
Expert Review of Anticancer Therapy|July 18, 2024
PROTACing the androgen receptor and other emerging therapeutics in prostate cancerPeter D Zang, Allen Seylani, Evan Y Yu, et al.
Cancer Treatment and Research|August 23, 2025
Immunotherapy in Renal Cell CarcinomaMiguel Zugman, Salvador Jaime-Casas, Peter D Zang, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|January 11, 2024
Immuno-Oncology Advances in Genitourinary CancersPeter D Zang, Arkhjamil Angeles, Tanya B Dorff, et al.
The Journal of Dermatological Treatment|November 8, 2019
Review of treatments for generalized pustular psoriasisDonovan G Kearns, Vipawee S Chat, Peter D Zang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 22, 2021
Novel Redirected T-Cell Immunotherapies for Advanced Prostate CancerTanya B Dorff, Vivek Narayan, Stephen J Forman, et al.
Cancer Research Communications|June 30, 2026
Comprehensive Profiling of Cell Surface Proteins in Testicular Germ Cell TumorsHedyeh Ebrahimi, Ali Moradi, Regina Barragan-Carrillo, et al.
Frontiers in Oncology|October 23, 2025
Efficacy and safety of antibody-drug conjugate combination therapy in advanced urothelial carcinomaSalvador Jaime-Casas, Regina Barragan-Carrillo, Miguel Zugman, et al.
JCO Precision Oncology|April 10, 2025
Comparative Genomic Characterization of Small Cell Carcinoma of the Bladder Compared With Urothelial Carcinoma and Small Cell Lung CarcinomaSalvador Jaime-Casas, Neal S Chawla, Nicholas J Salgia, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 18, 2025
IDO Believe in ImmunotherapyPeter D Zang, Tanya B Dorff
Annual Review of Medicine|November 21, 2024
CD70: An Emerging Anticancer Target in Renal Cell Carcinoma and BeyondPeter D Zang, Arkhjamil Angeles, Sumanta K Pal
Expert Review of Anticancer Therapy|July 18, 2024
PROTACing the androgen receptor and other emerging therapeutics in prostate cancerPeter D Zang, Allen Seylani, Evan Y Yu, et al.
Cancer Treatment and Research|August 23, 2025
Immunotherapy in Renal Cell CarcinomaMiguel Zugman, Salvador Jaime-Casas, Peter D Zang, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|January 11, 2024
Immuno-Oncology Advances in Genitourinary CancersPeter D Zang, Arkhjamil Angeles, Tanya B Dorff, et al.
The Journal of Dermatological Treatment|November 8, 2019
Review of treatments for generalized pustular psoriasisDonovan G Kearns, Vipawee S Chat, Peter D Zang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 22, 2021
Novel Redirected T-Cell Immunotherapies for Advanced Prostate CancerTanya B Dorff, Vivek Narayan, Stephen J Forman, et al.
Cancer Research Communications|June 30, 2026
Comprehensive Profiling of Cell Surface Proteins in Testicular Germ Cell TumorsHedyeh Ebrahimi, Ali Moradi, Regina Barragan-Carrillo, et al.
Frontiers in Oncology|October 23, 2025
Efficacy and safety of antibody-drug conjugate combination therapy in advanced urothelial carcinomaSalvador Jaime-Casas, Regina Barragan-Carrillo, Miguel Zugman, et al.
JCO Precision Oncology|April 10, 2025
Comparative Genomic Characterization of Small Cell Carcinoma of the Bladder Compared With Urothelial Carcinoma and Small Cell Lung CarcinomaSalvador Jaime-Casas, Neal S Chawla, Nicholas J Salgia, et al.
Pageof 2